- Patent Title: Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates
-
Application No.: US14439897Application Date: 2013-10-30
-
Publication No.: US09828428B2Publication Date: 2017-11-28
- Inventor: Dangshe Ma , Fang Jin , Lioudmila Gennadievna Tchistiakova , Puja Sapra
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Maria V. Marucci
- International Application: PCT/IB2013/059786 WO 20131030
- International Announcement: WO2014/072888 WO 20140515
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/48 ; G01N33/574 ; A61K39/395 ; A61K39/00
Abstract:
Disclosed herein are anti-IL-13-Rα2 antibodies and antibody drug conjugates and methods for preparing and using the same.
Public/Granted literature
- US20150266962A1 ANTI-IL-13 RECEPTOR ALPHA 2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES Public/Granted day:2015-09-24
Information query
